Vitamin D studies confirm correlations
Vitamin D
UK biobank
https://www.ukbiobank.ac.uk
Habitual use of vitamin D supplements and risk of coronavirus disease 2019 (COVID-19) infection: a prospective study in UK Biobank (29th January, 2021)
https://academic.oup.com/ajcn/advance-article/doi/10.1093/ajcn/nqaa381/6123965
The American Journal of Clinical Nutrition
Background
Vitamin D supplementation, lower risk of acute respiratory tract infection
Emerging evidence, vitamin D insufficiency is related to a higher risk of coronavirus infection and disease
Objectives
To investigate the prospective association between habitual use of vitamin D supplements and risk of COVID- 19 infection
Associations according to levels of circulating and genetically predicted vitamin D
Methods
N = 8,297 adults
Records of COVID-19 test results from UK Biobank
16 March 2020 to 29 June 2020
Results
Of the 8,297 adults, 1,374 (16.6%) tested positive
Vit D users, n = 363
Non-vit D users, n = 7,934
Unadjusted model
OR 0.78 (p = 0.105)
Adjustment for covariates
Age, sex, race, origin (outpatient or inpatient), blood-type, years of education, TDI, smoking, moderate drinking, physical activity, healthy diet score, use of any other supplements
Inverse association emerged
Between habitual use of vitamin D supplements and risk of COVID-19 infection
OR, 0.66, (P = 0.038)
Habitual use of vitamin D supplements was significantly associated with a 34% lower risk of COVID-19 infection
No association with baseline blood vitamin D levels and risk of COVID-19 infection
Associations between the risk of COVID-19 infection and habitual use of other individual supplements
Vitamin A, vitamin B, vitamin C, vitamin E, folic acid, a
multivitamin,
Calcium, zinc, iron, selenium, glucosamine, fish
Oil
Vitamin D Deficiency and Outcome of COVID-19 Patients
Medical University Hospital Heidelberg, (September 2020)
https://www.mdpi.com/2072-6643/12/9/2757
Identification of modifiable prognostic factors may help to improve outcomes
N = 185, diagnosed and treated in Heidelberg
Median Vitamin D level was 16.6 ng/ml
Associations of vitamin D status with disease severity and survival
Vitamin D status assessed at first presentation
Deficient
25-hydroxyvitamin D (Calcifediol)
level less than 12 ng/mL ( less than 30 nM)
N = 41 (22%)
Median IL-6 levels at hospitalization were significantly higher
70.5 versus 29.7 pg/mL
Insufficiency
Less than 20 ng/mL (less than 50 nM)
N = 118 (64%)
Higher levels
N = 26
Median Vitamin D level was significantly lower in the inpatient versus the outpatient subgroup
Results
Median observation period of 66 days
93 (50%) patients required hospitalization
28 patients required ventilation
Including 16 deaths
Adjusting for age, sex, comorbidities
Deficiency was associated with higher risk of ventilation and death
Mechanical ventilation
HR 6.12
p less than 0.001
Death
HR 14.73
p less than 0.001
Other hazard ratios
Male, 1.69 2.5
Over 60, 3.2 7.7
Comorbidity, 2.7 5.3
Need for interventional studies
Cholecalciferol
Calcifediol
Active form of vitamin D3, 1, 25-dihydroxyvitamin D3 (1,25D3), calcitriol, is
pluripotent hormone and important modulator of both innate and adaptive immunity
Видео Vitamin D studies confirm correlations канала Dr. John Campbell
UK biobank
https://www.ukbiobank.ac.uk
Habitual use of vitamin D supplements and risk of coronavirus disease 2019 (COVID-19) infection: a prospective study in UK Biobank (29th January, 2021)
https://academic.oup.com/ajcn/advance-article/doi/10.1093/ajcn/nqaa381/6123965
The American Journal of Clinical Nutrition
Background
Vitamin D supplementation, lower risk of acute respiratory tract infection
Emerging evidence, vitamin D insufficiency is related to a higher risk of coronavirus infection and disease
Objectives
To investigate the prospective association between habitual use of vitamin D supplements and risk of COVID- 19 infection
Associations according to levels of circulating and genetically predicted vitamin D
Methods
N = 8,297 adults
Records of COVID-19 test results from UK Biobank
16 March 2020 to 29 June 2020
Results
Of the 8,297 adults, 1,374 (16.6%) tested positive
Vit D users, n = 363
Non-vit D users, n = 7,934
Unadjusted model
OR 0.78 (p = 0.105)
Adjustment for covariates
Age, sex, race, origin (outpatient or inpatient), blood-type, years of education, TDI, smoking, moderate drinking, physical activity, healthy diet score, use of any other supplements
Inverse association emerged
Between habitual use of vitamin D supplements and risk of COVID-19 infection
OR, 0.66, (P = 0.038)
Habitual use of vitamin D supplements was significantly associated with a 34% lower risk of COVID-19 infection
No association with baseline blood vitamin D levels and risk of COVID-19 infection
Associations between the risk of COVID-19 infection and habitual use of other individual supplements
Vitamin A, vitamin B, vitamin C, vitamin E, folic acid, a
multivitamin,
Calcium, zinc, iron, selenium, glucosamine, fish
Oil
Vitamin D Deficiency and Outcome of COVID-19 Patients
Medical University Hospital Heidelberg, (September 2020)
https://www.mdpi.com/2072-6643/12/9/2757
Identification of modifiable prognostic factors may help to improve outcomes
N = 185, diagnosed and treated in Heidelberg
Median Vitamin D level was 16.6 ng/ml
Associations of vitamin D status with disease severity and survival
Vitamin D status assessed at first presentation
Deficient
25-hydroxyvitamin D (Calcifediol)
level less than 12 ng/mL ( less than 30 nM)
N = 41 (22%)
Median IL-6 levels at hospitalization were significantly higher
70.5 versus 29.7 pg/mL
Insufficiency
Less than 20 ng/mL (less than 50 nM)
N = 118 (64%)
Higher levels
N = 26
Median Vitamin D level was significantly lower in the inpatient versus the outpatient subgroup
Results
Median observation period of 66 days
93 (50%) patients required hospitalization
28 patients required ventilation
Including 16 deaths
Adjusting for age, sex, comorbidities
Deficiency was associated with higher risk of ventilation and death
Mechanical ventilation
HR 6.12
p less than 0.001
Death
HR 14.73
p less than 0.001
Other hazard ratios
Male, 1.69 2.5
Over 60, 3.2 7.7
Comorbidity, 2.7 5.3
Need for interventional studies
Cholecalciferol
Calcifediol
Active form of vitamin D3, 1, 25-dihydroxyvitamin D3 (1,25D3), calcitriol, is
pluripotent hormone and important modulator of both innate and adaptive immunity
Видео Vitamin D studies confirm correlations канала Dr. John Campbell
Показать
Комментарии отсутствуют
Информация о видео
Другие видео канала
Vaccine reduces spreadMouth wash, Colchicine and Vitamin DViral origins and vaccine supplyNew variant causes more symptomsFever, Fluids, Food in acute infectionsTwo new vaccines workSymptom tracker and the next pandemicVitamin D, Large scale studiesDefining feverEKG or ECG- Simple Simple!Mr David Davis MP and Vitamin DSleep Like a Baby: Myths About Insomnia and AgingAntibody data and US predictionsNew variant dangersAntigen survey shows high prevalenceUpdate and Brazil reportMarch dangers and homeopathyPost vaccination contagionUS changes, UK problemsDifficult COVID month ahead